Results 351 to 360 of about 1,198,663 (392)
A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer. [PDF]
Sci RepSa-Nguansai S +6 more
europepmc +1 more source
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort. [PDF]
BJC RepAugustinsson A +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
International Reviews of Immunology, 1990
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
Adjuvant activity of incomplete Freund's adjuvant
Advanced Drug Delivery Reviews, 1998The water-in-oil emulsion adjuvants developed by Jules Freund and coworkers have been, and continue to be, used in research and veterinary vaccines. Incomplete Freund's Adjuvant (IFA) has also been widely tested in humans where it was shown to augment antibody responses greater than other adjuvants, such as alum, and to be well tolerated.
Jay R Savary +3 more
openaire +3 more sources
Current HIV Research, 2010
The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Development of vaccines to combat mucosal infections represents a top priority. Mucosal immunization has recently attracted much interest as a means of generating protective immunity against mucosal pathogens.
HARANDI A. M., MEDAGLINI D.
openaire +4 more sources
The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Development of vaccines to combat mucosal infections represents a top priority. Mucosal immunization has recently attracted much interest as a means of generating protective immunity against mucosal pathogens.
HARANDI A. M., MEDAGLINI D.
openaire +4 more sources